My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2021-109A
CBCC
>
Official Documents
>
2020's
>
2021
>
2021-109A
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
11/17/2021 9:44:33 AM
Creation date
11/12/2021 3:36:05 PM
Metadata
Fields
Template:
Official Documents
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5B185859-5943-4C41-90BF-OCE5E90FDADD <br />(01/2021 Version) <br />PARTICIPATING <br />BRAND <br />$0.50 dispensing fee <br />GENERIC <br />1, MAINTENANCE <br />$0.50 dispensing fee <br />NETWORKREA'Al 'I <br />BRAND <br />$0.50 dispensing fee <br />GENERIC <br />$0.50 dispensing fee <br />BRAND <br />$0.00 dispensing fee <br />GENERIC <br />$0.00 dispensing fee <br />Claims Excluded: OTC products (excluding insulin, diabetic strips, and test strips), compounds, U&C claims, <br />Member Submitted Claims, Subrogation Claims, Coordination of Benefit Claims, Exclusive and Limited <br />Distribution Products/Claims, vaccines, Specialty Products (other than specialty guarantee) biosimilar <br />products (other than Specialty Product guarantee, if applicable), long term care pharmacy claims and/or <br />claims with ancillary charges and products filled through in-house or 340b pharmacies (if applicable). <br />Dispensing Fees are inclusive of shipping and handling. If carrier rates (i.e., U.S. mail and/or applicable <br />commercial courier services) increase during the Term of this Agreement, the Dispensing Fee guarantees <br />will be increased to reflect such increase(s). Notwithstanding the foregoing, Administrator guarantees that <br />Client will only be responsible for up to a twenty percent increase over the carrier rates of the previous <br />calendar year. At Client's request, Administrator will reimburse Client for any payments made in excess of <br />such twenty percent increase in carrier rates. <br />Guarantees will be measured and reconciled on an annual basis. The guarantees are annual guarantees - if <br />this Agreement is terminated prior to the completion of the then current contract year (hereinafter, a "Partial <br />Contract Year"), then the guarantees will not apply for such Partial Contract Year. To the extent Client <br />changes its benefit design or Formulary during the Term of the Agreement, the guarantee will be equitably <br />adjusted if there is a material impact on the discount achieved. Subject to the remaining terms of this <br />Agreement, Administrator will pay the difference of Client's cost for any shortfall between the actual result <br />and the guaranteed result. Shortfall payments for financial guarantees, if any, will not be paid until this <br />Agreement is signed. For purposes of measurement of any pricing guarantee in this Agreement or <br />Amendments to this Agreement; over performance in any component will not be used to offset performance <br />in any other measured pricing component. <br />Notwithstanding anything in this Agreement to the contrary, the Generic average annual ingredient cost <br />discount guarantees set forth above will include only those Prescription Drug Claims that processed to Client <br />for payment where the underlying prescription drug product was identified by Medi -Span as having a Multi - <br />Source Indicator code identifier of "Y" on the date dispensed (or was identified by Medi -Span as having a <br />Multi -Source Indicator identifier of an "M," "N," or "O" on the date dispensed, but was substituted and <br />dispensed by the Mail Service Pharmacy as its "house generic"), unless such Prescription Drug Claim is <br />otherwise excluded above. The Brand average annual ingredient discount guarantees set forth above will <br />include only those Prescription Drug Claims that processed to Client for payment where the underlying <br />prescription drug product was identified by Medi -Span as having a Multi -Source Indicator code identifier of <br />"M", "N", or "O" on the date dispensed (except in cases where the underlying prescription drug product was <br />substituted and dispensed by the Mail Service Pharmacy as its "house generic"), unless such Prescription <br />Drug Claim is otherwise excluded above. The application of brand and generic pricing may be subject to <br />certain "dispensed as written" (DAW) protocols and Client or Plan defined plan design and coverage policies <br />for adjudication and Member Copayment purposes. If Medi -Span discontinues reporting Multi -Source <br />Indicator identifiers, Administrator reserves the right to make an equitable adjustment as necessary to <br />maintain the parties' relative economics and the pricing intent of this Agreement. Notwithstanding anything <br />in this Agreement to the contrary, any rebate guarantees set forth in this Agreement will be reconciled using <br />ESI's proprietary brand/generic algorithm. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF EXPRESS SCRIPTS AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.